Association of visceral obesity with high viral load and histological findings in elderly patients with genotype 1 chronic hepatitis C

Internal Medicine

Volumn 52, Issue 15, 2013, Pages 1665-1673

  Tsuzura, Hironori ^a   Genda, Takuya ^a   Sato, Shunsuke ^a   Hirano, Katsuharu ^a   Kanemitsu, Yoshio ^a   Narita, Yutaka ^a   Kikuchi, Tetsu ^a   Iijima, Katsuyori ^a   Wada, Ryo ^b   Ichida, Takafumi ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY   (Japan)

Author keywords

Adiponectin; Chronic hepatitis C; Fibrosis; Steatosis; Viral load; Visceral obesity

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BODY MASS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FIBROSIS; GENETIC ASSOCIATION; GENOTYPE; HEPATITIS C; HISTOLOGY; HOMEOSTASIS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; OBESITY; PROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS LOAD;

ADIPOKINES; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COMORBIDITY; FEMALE; GENOTYPE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; OBESITY, ABDOMINAL; PREVALENCE; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; VIRAL LOAD;

EID: 84880975512     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.9430     Document Type: Article

References (35)

1. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepati-tis C virus infection. Lancet Infect Dis 5: 558-567, 2005.
2. Lauer G, Walker BD. Hepatitis C virus infection. N Engl J Med 345: 41-52, 2001.
3. Alberti A, Noventa F, Benvegnu L, Boccato S, Gatta A. Preva-lence of liver disease in a population of asymptomatic persons with hepatitis C virus infection. Ann Intern Med 137: 961-964, 2002.
4. Asselah T, Rubbia-Brandt L, Marcellin P, Negro F. Steatosis in chronic hepatitis C: why does it really matter? Gut 55: 123-130, 2006.
5. Camma C, Bruno S, Di Marco V, et al. Insulin resistance is asso-ciated with steatosis in nondiabetic patients with genotype 1 chronic hepatitis C. Hepatology 43: 64-71, 2006.
6. Petta S, Camma C, Di Marco V, et al. Insulin resistance and dia-betes increase fibrosis in the liver of patients with genotype 1 HCV infection. Am J Gastroenterol 103: 1136-1144, 2008.
7. Hourigan LF, Macdonald GA, Purdie D, et al. Fibrosis in chronic hepatitis C correlates significantly with body mass index and stea-tosis. Hepatology 29: 1215-1219, 1999.
8. Adinofi LE, Gamdardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. Hepatology 33: 1358-1364, 2001.
9. Patton HM, Patel K, Behling C, et al. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients. J Hepatol 40: 484-490, 2004.
10. Romero-Gomez M, Del Mar Viloria M, Andrade RJ, et al. Insulin resistance impairs sustained response rate to peginterferon plus ribavirin in chronic hepatitis C patients. Gastroenterology 128: 636-641, 2005.
11. Sato S, Genda T, Hirano K, et al. Differences in the factors asso-ciated with serum viral load between genotype 1 and 2 in patients with chronic hepatitis C. Hepatol Int 2011: epub ahead of print.
12. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 89: 2548-2556, 2004.
13. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation, and insu-lin resistance. Gastroenterology 128: 636-641, 2005.
14. Despres JP, Lemieux I. Abdominal obesity and metabolic syn-drome. Nature 444: 881-887, 2006.
15. Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syn-drome among US adults: finding from the Third National Health and Nutrition Examination Survey. JAMA 287: 356-359, 2002.
16. Kobayashi J, Nishimura K, Matoba M, Maekawa N, Mabuchi H. Generation and gender differences in the components contributing to the diagnosis of the metabolic syndrome according to the Japa-nese criteria. Circ J 71: 1734-1737, 2007.
17. Sakurai T, Iimuro S, Araki A, et al. Age-associated increase in ab-dominal obesity and insulin resistance, and usefulness of AHA-NHLBI definition of metabolic syndrome for predicting cardiovas-cular disease in Japanese elderly with type 2 Diabetes Mellitus. Gerontology 56: 141-149, 2010.
18. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: stan-dardized technique for measurement at CT. Radiology 211: 283-286, 1999.
19. Oka R, Kobayashi J, Yagi K, et al. Reassessment of the cutoff val-ues of waist circumference and visceral fat area for identifying Japanese subjects at risk for the metabolic syndrome. Diabetes Res Clin Pract 79: 474-481, 2008.
20. Matsuzawa Y. Metabolic syndrome-definition and diagnostic crite-ria in Japan. J Atheroscler Thromb 12: 301, 2005.
21. Alberti KG, Zimmer PZ. Definition, diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 15: 539-553, 1998.
22. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 19: 1513-1520, 1994.
23. Poynald T, Bedossa P, Opoion P. Natural history of liver fibrosis in patients with chronic hepatitis C. Lancet 349: 825-832, 1997.
24. Hadziyannis SJ, Sette H, Morgan TR, et al. Peginterferon-alpha2a and ribavirin combination therapy in chronic hepatitis C: random-ized study of treatment duration and ribavirin dose. Ann Intern Med 140: 346-355, 2004.
25. Gordon SC, Dailey PJ, Silverman AL, Khan BA, Kodali VP, Wil-ber JC. Sequential serum hepatitis C viral RNA levels longitudi-nally assessed by branched DNA signal amplification. Hepatlogy 28: 1702-1706, 1998.
26. Yoshimura E, Hayashi J, Ueno K, et al. No significant changes in levels of hepatitis C virus (HCV) RNA by competitive polymerase chain reaction in blood samples from patients with chronic HCV infection. Dig Dis Sci 42: 772-777, 1997.
27. Moucari R, Asselah T, Cazals-Hatem D, et al. Insulin resistance in chronic hepatitis C: association with genotype 1 and 4, serum HCV RNA level, and liver fibrosis. Gastroenterology 134: 416-423, 2008.
28. Hsu CS, Liu CH, Liu CJ, et al. Association of lipid profiles with hepatitis C viral load in chronic hepatitis C patients with genotype 1 or 2 infection. Am J Gastroenterol 104: 598-604, 2009.
29. Petta S, Amato M, Cabibi D, et al. Visceral adiposity index is as-sociated with histological findings and high viral load in patients with chronic hepatitis C due to genotype 1. Hepatology 52: 1543-1552, 2010.
30. Chayama K, Hayes CN, Yoshioka K, et al. Accumulation of re-fractory factors for pegylated interferon plus ribavirin therapy in older female patients with chronic hepatitis C. Hepatol Res 40: 1155-1167, 2010.
31. Kobayashi M, Suzuki F, Akuta N, et al. Association of two poly-morphisms of the IL28B gene with viral factors and treatment re-sponse in 1,518 patients infected with hepatitis C Virus. J Gastro-enterol 47: 834-844, 2012.
32. Yoneda M, Saito S, Ikeda T, et al. Hepatitis C virus directly asso-ciates with insulin resistance independent of the visceral fat area in nonobese and nondiabeic patients. J Viral Hepat 14: 600-607, 2007.
33. Park BJ, Kim YJ, Kim DH, et al. Visceral adipose tissue area is an independent risk factor for hepatic steatosis. J Gastroenterol Hepatol 23: 900-907, 2008.
34. Gonzalez-Reimers E, Castellano-Higuera A, Aleman-Valls R, et al. Relation between body fat and liver fat accumulation and cytokine pattern in non-alcoholic patients with chronic HCV infection. Ann Nutr Metab 55: 351-357, 2009.
35. Palmer C, Hampartzoumian T, Lioyd A, Zekry A. A novel role for adiponectin in regulating the immune responses in chronic hepati-tis C virus infection. Hepatology 48: 374-384, 2008.